232 related articles for article (PubMed ID: 31454780)
1. Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.
Stengel H; Vural A; Brunder AM; Heinius A; Appeltshauser L; Fiebig B; Giese F; Dresel C; Papagianni A; Birklein F; Weis J; Huchtemann T; Schmidt C; Körtvelyessy P; Villmann C; Meinl E; Sommer C; Leypoldt F; Doppler K
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454780
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
4. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
6. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
[TBL] [Abstract][Full Text] [Related]
7. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
[TBL] [Abstract][Full Text] [Related]
8. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
9. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis.
Yan W; Nguyen T; Yuki N; Ji Q; Yiannikas C; Pollard JD; Mathey EK
J Neuroimmunol; 2014 Dec; 277(1-2):13-7. PubMed ID: 25262157
[TBL] [Abstract][Full Text] [Related]
11. Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies.
Bailly L; Mongin M; Delorme C; Apartis E; Saheb S; Viala K; Roze E
Tremor Other Hyperkinet Mov (N Y); 2018; 8():606. PubMed ID: 30619643
[TBL] [Abstract][Full Text] [Related]
12. Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.
Doppler K; Stengel H; Appeltshauser L; Grosskreutz J; Man Ng JK; Meinl E; Sommer C
J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1145-1151. PubMed ID: 29945879
[TBL] [Abstract][Full Text] [Related]
13. Neurofascin as a target for autoantibodies in peripheral neuropathies.
Ng JK; Malotka J; Kawakami N; Derfuss T; Khademi M; Olsson T; Linington C; Odaka M; Tackenberg B; Prüss H; Schwab JM; Harms L; Harms H; Sommer C; Rasband MN; Eshed-Eisenbach Y; Peles E; Hohlfeld R; Yuki N; Dornmair K; Meinl E
Neurology; 2012 Dec; 79(23):2241-8. PubMed ID: 23100406
[TBL] [Abstract][Full Text] [Related]
14. Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy.
Appeltshauser L; Brunder AM; Heinius A; Körtvélyessy P; Wandinger KP; Junker R; Villmann C; Sommer C; Leypoldt F; Doppler K
Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32736337
[TBL] [Abstract][Full Text] [Related]
15. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
16. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
Appeltshauser L; Junghof H; Messinger J; Linke J; Haarmann A; Ayzenberg I; Baka P; Dorst J; Fisse AL; Grüter T; Hauschildt V; Jörk A; Leypoldt F; Mäurer M; Meinl E; Michels S; Motte J; Pitarokoili K; Stettner M; Villmann C; Weihrauch M; Welte GS; Zerr I; Heinze KG; Sommer C; Doppler K
Brain; 2023 May; 146(5):1932-1949. PubMed ID: 36346134
[TBL] [Abstract][Full Text] [Related]
17. Anti-pan-neurofascin nodopathy: cause of fulminant neuropathy.
Acerra GM; Bevilacqua L; Noioso CM; Valle PD; Serio M; Vinciguerra C; Piscosquito G; Toriello A; Vegezzi E; Gastaldi M; Barone P; Iovino A
Neurol Sci; 2024 Apr; 45(4):1755-1759. PubMed ID: 38190082
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
[TBL] [Abstract][Full Text] [Related]
19. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.
Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC
Muscle Nerve; 2018 May; 57(5):848-851. PubMed ID: 29130507
[TBL] [Abstract][Full Text] [Related]
20. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
